The CAR T-Cell Race, The Scientist Magazine

The CAR T-Cell Race Tumor-targeting T-cell therapies are generating remarkable remissions in hard-to-beat cancers–and attracting millions of dollars of investment along the way. By Vicki Brower | April 1, 2015 BUILDING A BETTER T-CELL: By modifying T cells to express chimeric antigen receptors (CARs) that recognize cancer-specific antigens, researchers can prime the cells to recognize […]